Search Go
Follow Us:  linkedin twitter slideshare youtube google + pinterest

Roles & Key Activities of Medical Affairs in New Product Planning

CHAPEL HILL, N.C., Oct. 3, 2014 /PRNewswire/ -- Pharmaceutical and biotech companies are constantly being faced with the dueling challenges of delivering innovative new products while also keeping development costs low. In order to cope with these challenges, organizations look to New Product Planning teams to play a vital role in many of the activities that set the stage for a successful launch.

According to research by benchmarking firm, Best Practices, LLC, medical affairs leaders are increasingly participating in activities such as ad boards, KOL identification & management, clinical trial strategy & planning, and publication strategy & planning. The central challenge is to ensure that the right new products get developed efficiently-with minimum risk and maximum value.

The related report, "New Product Planning: Role and Activities for Medical Affairs," provides Medical Affairs leaders insights into the timing and value of key activities. In addition, the report provides narratives from new product planning veterans on how organizations approach these critical activities.

The report provides drill down for each of the following activities in terms of their timing, intended outcomes, and value for the organization:
  • Advisory Boards
  • Brand of the Science
  • KOL Identification
  • KOL Management
  • Medical Meeting Planning
  • Non-Registration Trials Strategy and Planning
  • Publication Strategy and Planning

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link:

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at


Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information